🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 20 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
21/10/2019 86,02 88,33 85,11 86,62 +0,99% 3,74% 859.300
18/10/2019 87,40 88,40 85,70 85,77 -1,91% 3,09% 809.300
17/10/2019 87,46 88,23 86,29 87,44 +0,81% 2,22% 771.800
16/10/2019 87,24 88,97 86,06 86,74 -1,49% 3,34% 776.300
15/10/2019 85,67 89,37 85,23 88,05 +2,74% 4,83% 914.400
14/10/2019 83,05 86,17 82,01 85,70 +2,66% 5,01% 551.700
11/10/2019 83,94 85,12 82,69 83,48 +0,38% 2,89% 876.000
10/10/2019 81,10 85,14 80,55 83,16 +2,95% 5,66% 880.500
09/10/2019 81,11 82,87 80,14 80,78 +0,32% 3,37% 1.094.900
08/10/2019 79,61 82,30 79,09 80,52 -0,54% 4,03% 1.554.400
07/10/2019 87,90 88,98 80,50 80,96 -8,26% 9,65% 2.852.600
04/10/2019 86,00 89,25 85,50 88,25 +8,50% 4,36% 6.021.800
03/10/2019 77,10 82,43 77,10 81,34 +4,70% 6,91% 2.839.700
02/10/2019 76,54 77,73 73,72 77,69 +1,52% 5,24% 1.343.100
01/10/2019 75,20 77,77 74,86 76,53 +1,61% 3,87% 1.066.700
30/09/2019 76,29 77,00 73,62 75,32 +0,43% 4,43% 1.146.000
27/09/2019 72,94 77,24 72,62 75,00 +3,01% 6,33% 1.541.400
26/09/2019 76,41 76,99 72,05 72,81 -4,15% 6,47% 1.627.400
25/09/2019 78,07 80,17 74,26 75,96 -2,30% 7,57% 1.792.600
24/09/2019 80,37 80,78 77,09 77,75 -3,27% 4,59% 1.429.800
23/09/2019 82,55 82,83 80,12 80,38 -2,58% 3,28% 1.009.600
20/09/2019 85,61 85,70 82,03 82,51 -3,34% 4,29% 1.913.800
19/09/2019 83,72 85,92 81,63 85,36 +2,02% 5,12% 1.175.800
18/09/2019 84,50 84,80 81,33 83,67 -1,43% 4,11% 1.578.600
17/09/2019 87,41 88,15 83,91 84,88 -2,46% 4,85% 1.552.200
16/09/2019 86,16 87,44 86,03 87,02 +1,19% 1,64% 928.800
13/09/2019 87,79 88,94 85,67 86,00 -2,25% 3,72% 1.057.100
12/09/2019 88,72 90,99 87,33 87,98 -1,23% 4,13% 1.201.100
11/09/2019 91,10 91,67 87,81 89,08 -2,19% 4,24% 1.329.100
10/09/2019 86,25 91,12 85,85 91,07 +5,11% 6,11% 2.027.500